FDA Grants Fast Track Status to TTS Cancer Project (non-small cell lung cancer)

The US Food and Drug Administration (FDA) has granted fast track status to Active Biotech's candidate drug TTS CD3 for the treatment of non-small cell lung cancer... click link for more info.

Continue to FDA Grants Fast Track Status to TTS Cancer Project (non-small cell lung cancer) on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz